Remove solutions trial-design-protocol-planning
article thumbnail

December 12, 2023: A Year of New Insights From the NIH Pragmatic Trials Collaboratory

Rethinking Clinical Trials

Investigators from the NIH Pragmatic Trials Collaboratory in 2023 shared study results, generated new knowledge, and developed innovative methods in the design, conduct, and analysis of pragmatic clinical trials.

Trials 141
article thumbnail

Improving trial predictability: leveraging AI-powered analytics to guide trial design, strategy, and operations

pharmaphorum

Enrolling for clinical trials has become more challenging in recent years, with trial competition, increasingly complex protocols, and precision medicine targeting more niche patient populations. Critical analysis in protocol design. per protocol, respectively. Country expansion to support enrolment.

Trials 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

WCG Launches 360 Protocol Assessment™ Solution to Ensure Protocol Quality by Design

WCG Clinical

This process decreases the number of required protocol amendments and highlights key risks and mitigations during the planning phase of the trial. The 360 Protocol Assessment provides a holistic view of a sponsor’s protocol to ensure quality by design.

article thumbnail

Comprehensive Guide on Risk-Based Monitoring (RBM)

Cloudbyz

Clinical trials are the cornerstone of drug development and medical research. One of the most significant challenges in conducting clinical trials is ensuring data quality and patient safety while managing costs effectively. Enter Risk-Based Monitoring (RBM), a paradigm shift in the world of clinical trials.

article thumbnail

The Winning Formula For Life Sciences: Salesforce Life Sciences Cloud And Cloudbyz eClinical Solutions Collaboration

Cloudbyz

Combined with Cloudbyz eClinical which is built natively on the Salesforce platform, this collaboration promises to revolutionize the way life science organizations manage their clinical trials and research processes. This integration ensures data consistency, eliminates silos, and enhances overall visibility across the organization.

article thumbnail

Key operational considerations to optimise decentralised clinical trials

pharmaphorum

Now that the COVID-19 pandemic has provided the industry with a solid foundation of experience with decentralised trials, it is appropriate to reflect and ask whether DCT studies are truly helping to address long-standing issues in research and development for sponsors, study teams and, most importantly, patients.

article thumbnail

Tech innovations that curb complexity, setting clinical trials up for success

Pharmaceutical Technology

There is no denying that trial complexity is continuing to increase. Several factors in recent years have contributed to this rise including more complex trial designs, the rapid adoption of decentralisation stemming from the pandemic, and larger global trials. Demand planning drives trial efficiency.